Callahan, Margaret K <br/><br/>
Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists.  [electronic resource] 

 -  Seminars in oncology  Aug 2015 
 - 573-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1532-8708 
<br/><br/><label>Standard No.: </label>10.1053/j.seminoncol.2015.05.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies--pharmacology<br/>Antibodies, Monoclonal--pharmacology<br/>Biomarkers--metabolism<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Humans<br/>Ipilimumab<br/>Neoplasms--drug therapy